Cargando…
Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis
This study establishes a proof-of-concept that a tattoo device can target intra-dermal drug delivery against cutaneous leishmaniasis (CL). The selected drug is oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion. We first show that treatment of cul...
Autores principales: | Shio, Marina Temi, Paquet, Marilene, Martel, Caroline, Bosschaerts, Tom, Stienstra, Stef, Olivier, Martin, Fortin, Anny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932479/ https://www.ncbi.nlm.nih.gov/pubmed/24561704 http://dx.doi.org/10.1038/srep04156 |
Ejemplares similares
-
Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis
por: Fortin, Anny, et al.
Publicado: (2014) -
Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine
por: Dorlo, Thomas P. C., et al.
Publicado: (2011) -
Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis
por: Van Bocxlaer, Katrien, et al.
Publicado: (2021) -
Socio-epidemiologic aspects and cutaneous side effects of permanent tattoos in Germany – Tattoos are not restricted to a specific social phenotype
por: Müller, Cornelia Sigrid Lissi, et al.
Publicado: (2016) -
Cutaneous Malignancies in Tattoos, a Case Series of Six Patients
por: Leijs, Marike, et al.
Publicado: (2021)